Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Dipna Pharmachem Ltd

BSE: 543594 · Pharmaceuticals & Biotechnology · 10 announcements

Share price
₹4.04
Market cap
₹10.62 Cr
Revenue (annual)
₹129.1 Cr
Net profit (annual)
₹2.63 Cr
P/E (TTM)
4.0×Sector 47.4×
Promoter holding
9.13%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:52 IST BSE
Annual General Meeting

Dipna Pharmachem Annual General Meeting

Shareholders approved appointing M/s. Jay Pandya & Associates as Secretarial Auditor for FY 2025-26 via postal ballot. The resolution passed with a 99.77% majority.

17:07 IST BSE
Annual General Meeting

Dipna Pharmachem Annual General Meeting

Dipna Pharmachem Limited has published newspaper advertisements confirming the dispatch of postal ballot notices and providing details for remote e-voting. The advertisements appeared in Financial Express (English and Gujarati) on April 24, 2026. This filing is in compliance with SEBI Listing Obligations and Disclosure Requirements Regulations.

15:04 IST BSE
Annual General Meeting

Dipna Pharmachem Annual General Meeting

Dipna Pharmachem Limited has issued a Postal Ballot Notice to appoint M/s. Jay Pandya & Associates as Secretarial Auditor for FY 2025-26. The remote e-voting period runs from April 23, 2026, to May 22, 2026. This is a routine regulatory procedure to obtain member consent for statutory compliance requirements.

Execution
Financial year 2025-26